Trials / Conditions / Refractory Acute Leukemia

Refractory Acute Leukemia

11 registered clinical trials studyying Refractory Acute Leukemia — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of Revumenib and Mezigdomide in People With Leukemia NCT07356154	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2
Withdrawn	A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating Wit NCT06474663	M.D. Anderson Cancer Center	Phase 1
Recruiting	A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory NCT06466395	M.D. Anderson Cancer Center	Phase 1
Recruiting	A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relap NCT06397027	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia NCT05029141	The First Affiliated Hospital of Soochow University	Phase 2
Completed	Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies NCT04681105	City of Hope Medical Center	Phase 1
Active Not Recruiting	Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed A NCT03834961	Children's Oncology Group	Phase 2
Terminated	Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukem NCT03735875	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Terminated	A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refr NCT01701375	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1
Unknown	Allo-Allo Tandem Bone Marrow Transplant (BMT) NCT00984412	Hadassah Medical Organization	Phase 1 / Phase 2
Completed	Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias NCT00410423	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1 / Phase 2